It is possible, if you lay the groundwork, to provide patients with acute leukemias with aggressive and effective therapies, while still allowing them to maintain quality of life, explained Jennifer Vaughn, MD, of The Ohio State University Comprehensive Cancer Center – James Cancer Hospital.
Typically, patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) receive aggressive chemotherapy treatment that requires long hospital stays, but it is possible to put the foundation in place for these patients to receive support in the outpatient setting in order for them to maintain quality of life and remain close to the people who matter to them, explained Jennifer Vaughn, MD, of The Ohio State University Comprehensive Cancer Center – James Cancer Hospital.
Transcript
Your earlier research has shown the benefits of early discharge to an outpatient setting after intensive chemotherapy for AML or MDS. Does this still hold true? And how can value-based care enhance this practice?
So that was a study that I participated in during my fellowship at the University of Washington Fred Hutch Cancer Center. And yes, I absolutely do think that its findings are relevant, primarily because the patients with acute leukemias who are eligible to receive higher doses of chemotherapy or attempt the curative therapy, still, the treatment remains the same: it's still very high doses of chemo followed often—at most institutions—by a very prolonged hospital stay. As you can imagine, this really influences the mental health and quality of life of a patient who is not only now dealing with a new very serious cancer diagnosis and the side effects of their treatment, but also become very isolated from things that they love to do on a daily basis. It becomes more difficult for them to see the people that they like to spend time with. In addition to that, it becomes very hard on the caregivers as well.
The goal of that study was to try to provide patients with equivalent, aggressive, and effective care but also allow them to improve their overall experience in the posttreatment setting. I think that is something we should always be striving to do but do it in a safe manner. As we said in the study, it was extremely important for us to have outpatient resources and supportive care, space, and providers in place in order to provide the much needed supportive therapy that they need after treatments. This should only be done with the greatest thought that goes into laying the groundwork for it ahead of time and knowing that you have the space and resources and expertise to be able to provide it.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More